Moreover, He et al. (118) demonstrated that IGF2BP1 interacts with glioma-associated oncogene homologue 1 (GLI1) mRNA, which is involved in HCC progression; the liver-specific lncRNA LINC01093 disrupts this interaction. This evidence concerns the gene IGF2BP1 and hepatocellular carcinoma.